Abstract
Intensive care unit readmissions are associated with mortality and bad outcomes. Machine learning could help to identify patients at risk to improve discharge decisions. However, many models are black boxes, so that dangerous properties might remain unnoticed. In this study, an inherently interpretable model for 3-day ICU readmission prediction was developed. We used a retrospective cohort of 15,589 ICU stays and 169 variables collected between 2006 and 2019. A team of doctors inspected the model, checked the plausibility of each component, and removed problematic parts. Qualitative feedback revealed several challenges for interpretable machine learning in healthcare. The resulting model used 67 features and showed an area under the precision-recall curve of 0.119±0.020 and an area under the receiver operating characteristic curve of 0.680±0.025. This is on par with state-of-the-art gradient boosting machines and outperforms the Simplified Acute Physiology Score II. External validation with the Medical Information Mart for Intensive Care database version IV confirmed our findings. Hence, a machine learning model for readmission prediction with a high level of human control is feasible without sacrificing performance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Financial Support by German Research Foundation (Deutsche Forschungsgemeinschaft, DFG grant DU 352/11-2).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical review board of the medical chamber Westfalen-Lippe gave ethical approval for this work (reference number: 2020-526-f-S).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data of the UKM cohort used to develop the ML models cannot be published due to privacy concerns. To access MIMIC-IV it is necessary to complete an online course on data usage and a data use agreement must be signed. Code for data preprocessing and all experiments publicly available: https://doi.org/10.5281/zenodo.5627167, https://doi.org/10.5281/zenodo.5541443.
